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C A N C E R
Circadian disruption promotes tumor-immune 
microenvironment remodeling favoring tumor  
cell proliferation
I. Aiello1,2*, M. L. Mul Fedele1*, F. Román1, L. Marpegan1, C. Caldart1, J. J. Chiesa1, 
D. A. Golombek1†, C. V. Finkielstein2†, N. Paladino1
Circadian disruption negatively affects physiology, posing a global health threat that manifests in proliferative, 
metabolic, and immune diseases, among others. Because outputs of the circadian clock regulate daily fluctuations 
in the immune response, we determined whether circadian disruption results in tumor-associated immune cell 
remodeling, facilitating tumor growth. Our findings show that tumor growth rate increased and latency decreased 
under circadian disruption conditions compared to normal light-dark (LD) schedules in a murine melanoma model. 
Circadian disruption induced the loss or inversion of daily patterns of M1 (proinflammatory) and M2 (anti- 
inflammatory) macrophages and cytokine levels in spleen and tumor tissues. Circadian disruption also induced (i) 
deregulation of rhythmic expression of clock genes and (ii) of cyclin genes in the liver, (iii) increased CcnA2 levels 
in the tumor, and (iv) dampened expression of the cell cycle inhibitor p21WAF/CIP1, all of which contribute to a pro-
liferative phenotype.
INTRODUCTION
The circadian clock is responsible for the generation and entrainment 
of rhythms for almost all physiological and behavioral functions of 
the body (e.g., body temperature, hormonal secretion, sleep, and 
locomotor activity), enabling adaptation to cyclic environmental 
changes. The molecular mechanism of the circadian clock arises from 
negative transcriptional feedback, which generates oscillations with 
periods close to 24 hours. In mammals, the core loop includes the 
positive elements Clock and Bmal1, inducing the expression of the 
negative elements Per1 to Per3 and Cry1 and Cry2, which, in turn, 
repress the transcriptional activity of the positive elements in a pro-
cess where compartmentalization, shuttling, and posttranslational 
events determine the pace of the circadian clock (1). This cell- 
autonomous pacemaker mechanism has been found in almost every 
cell in the body. The main biological clock resides in the hypotha-
lamic suprachiasmatic nuclei (SCN), and the principal environmen-
tal signal that adjusts its activity is the light-dark (LD) cycle. In turn, 
the SCN controls circadian oscillators in peripheral tissues (e.g., 
liver, lung, and other brain areas) through neural, hormonal, and 
behavioral pathways to maintain an optimal phase relation between 
them and with the environment (2).
In mammals, shifting the activity period to an atypical time of 
the day (e.g., by shift work or jet lag in humans) causes a temporal 
misalignment that, under chronic conditions, might result in dis-
ease onset (e.g., cardiometabolic syndromes, obesity, and cancer) and 
physical and mental health disorders. Whereas these findings were 
initially brought to our attention by epidemiological studies, the use 
of animal models has been pivotal to uncovering the genetic and 
environmental links that, when compromised by circadian dis-
ruption, lead to disease onset [reviewed in (3)]. A case in point was 
the initial finding that tumor-bearing mice increased their tumor 
growth rate when exposed to experimental chronic jet lag (CJL), 
constant light (LL), or other alterations of the molecular circadian 
clock (3). Whole genome-wide transcript profiling showed that 
~10% of the cell transcriptome, including genes involved in cell cy-
cle transition, response to DNA damage, and cell death processes, 
were under circadian control [reviewed in (4)], all of which suggest 
a relevant role for clock components in establishing proliferative 
disorders.
The development of cancer and its response to therapeutic pro-
tocols are strongly influenced by innate and adaptive immune systems, 
which either promote or attenuate tumorigenesis. As the circadian 
clock modulates several immune parameters including the number 
of different cell types (e.g., macrophages and CD4+ and CD8+ T cells) 
in different tissues (e.g., peripheral blood and spleen), daily cyto-
kine fluctuations, phagocytic activity, and response to the immune 
challenge (e.g., lipopolysaccharide) [reviewed in (5)], its derange-
ment deregulates the inflammatory processes that are predicted to 
favor establishment and progression of tumors (6). Specifically, mac-
rophages can differentiate into two functional profiles, M1 and M2. 
The M1 phenotype is more closely associated with inflammatory 
antitumor immunity, whereas the M2 phenotype, a more function-
ally diverse subset of macrophages, exhibits immunosuppressive 
and homeostatic functions (7). Chronic inflammation can promote 
tumor development and progression; nevertheless, the balance be-
tween the activation of immunological tolerance and inflammatory 
pathways is certainly relevant to tumor immunity. Tumor-specific 
or tumor-associated antigens can activate antitumor immune re-
sponses by dendritic cells (DCs) and M1 macrophage–mediated 
activation of cytotoxic T lymphocytes and natural killer (NK) cells. 
In addition, induction of tolerance can be achieved by recruitment 
to the tumor microenvironment and differentiation of immuno-
suppressive cells such as M2 macrophages, myeloid-derived sup-
pressor cells (MDSCs), tumor-associated neutrophils, and regulatory 
T cells (Tregs) [reviewed in (8)].
The aim of this study was to analyze the impact of chronic circa-
dian derangement in tumor-immune microenvironment remodel-
ing and tumor growth in a nonmetastatic melanoma mouse model.
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RESULTS
Circadian disruption promotes tumor growth
To understand the effect of a circadian disruption protocol on the 
rate of tumor growth, mice were maintained under an experimental 
LD (LD12:12) or CJL schedule [6-hour advance of the LD12:12 cy-
cle every 2 days (9)] for 3 weeks before they were subcutaneously 
challenged with B16F0 nonmetastatic melanoma cells. Following 
inoculation, animals were maintained under each experimental light 
schedule, i.e., LD or CJL, until reaching the end point of the tumor 
protocol as defined in Materials and Methods. We chose to work 
with B16F0 cells because their tumor growth rate in vivo is modu-
lated by the immune system (10).
First, we recapitulated the circadian disruption tumor growth 
model in vivo in CJL-treated mice and compared tumor growth to 
matching points in mice maintained under LD conditions. Tumor 
size under circadian desynchronization increased significantly com-
pared to those grown under LD conditions (P < 0.01; Fig. 1A). 
Moreover, the survival curve was significantly different between the 
CJL and LD mice groups (P = 0.0153; Fig. 1B). In addition, tumor 
latency, measured as the elapsed time between the injection of B16F0 
cells and the moment a palpable tumor was detectable in the animal 
(vol.t ~ 1 mm3), was 15 ± 0.85 days after inoculation in CJL versus 
25.8 ± 3.64 days in LD treated-animals (P = 0.037; Fig. 1C).
We then determined whether alterations in the light schedule 
influenced tumor vasculogenesis. We found that, whereas the num-
ber of blood vessels around the site of tumor cell inoculation (1 week 
after injection) remained comparable between both circadian pro-
tocols (fig. S1, A and B), the number of intratumor blood vessels 
(vol.t of 2000 to 2500 mm3) increased significantly under CJL con-
ditions (P = 0.0007; fig. S1, C and D).
Circadian desynchronization promotes tumor-immune 
microenvironment remodeling
Because the composition of the tumor-immune microenvironment 
influences tumor growth and shapes therapeutic treatments (11), 
we determined whether circadian disruption could influence the 
proportion of various immune cells in the tumor microenvironment 
and, in turn, favor tumor progression. Accordingly, we first exam-
ined the percentage of different tumor-infiltrating leukocytes in tu-
mor samples collected over a 24-hour period [Zeitgeber time 3 (ZT3), 
ZT9, ZT15, and ZT21] from animals maintained in either constant 
LD or chronic circadian disruption (CJL) schedules (Fig. 2 and fig. S2). 
Because there were no significant differences between data obtained 
in ZT3 and ZT9 or between ZT15 and ZT21, we grouped the values 
obtained during the day (ZT3 and ZT9) and night (ZT15 and ZT21) 
and summarized them as diurnal and nocturnal data, respectively 
(table S1).
We evaluated the percentage of total macrophages within tumor 
samples and did not observe significant differences between time 
points [LD: ZT3: 52.2 ± 8.97%, ZT9: 51.48 ± 8.34%, ZT15: 55.16 ± 
4.08%, ZT21: 31.08 ± 6.83%; CJL: ZT3: 56.32 ± 5.08%, ZT9: 47.04%, 
ZT15: 28.2 ± 8.46%, ZT21: 28.08 ± 9.98%; P = n.s. (not significant); 
table S1]. However, our results show several remarkable changes in 
M1 and M2 macrophage levels between the two experimental con-
ditions (Fig. 2). Under LD exposure, M1 macrophages exhibited a 
nearly twofold increase in their levels at ZT15 and ZT21 compared 
to ZT9 (P < 0.05; Fig. 2A), while in animals exposed to CJL this 
difference was inverted, showing higher levels at ZT9 (P < 0.05; 
Fig. 2A). Despite the lack of significant differences between time 
points in the levels of M2 cells (Fig. 2B), we found interesting results 
when comparing diurnal versus nocturnal levels. Under LD expo-
sure, M1 and M2 macrophage levels were in antiphase, with an in-
crease in the level of M1 cells during the night (LD Day versus LD 
Night: P = 0.004; table S1) and a comparable reduction of M2 cells 
in this phase (LD Day versus LD Night: P = 0.003; table S1). The 
distribution of M1 and M2 cells in tumors from animals exposed to 
CJL exhibited a sharp contrast with that of LD animals (table S1). 
Whereas chronic circadian disruption reversed and dampened the 
levels of M1-infiltrated cells in the tumor (CJL Day versus CJL Night: 
P = 0.049; LD Night versus CJL Night: P = 0.0004; table S1), the 
levels of M2 macrophages lost their day-night differences and re-
mained constant throughout the whole cycle (CJL Day versus CJL 
Night: P = n.s., LD Day versus CJL Day: P = 0.017; table S1). These 
results indicate that circadian disruption induces important changes 
in the composition of the tumor-infiltrated immune cells at differ-
ent times of the day.
Because M1 and M2 cells have opposite functions and can in-
hibit one another, the M1/M2 ratio has a predictive value on tumor 
growth (12). Although we did not observe substantial differences 
among time points (Fig. 2C), tumors from animals under LD ex-
hibited a ratio that favored M1-mediated immunostimulation 
and tumor suppressor activity during the night and a more tumor- 
prone phenotype characterized by M2-mediated immune sup-
pression during the day (LD Day versus LD Night: P = 0.0028; table 
S1). These temporal differences in infiltration were blunted in 
CJL animals, favoring a phenotype in which tumor progression is 
Fig. 1. Characterization of tumor growth and animal survival under CJL schedules. Mean ± SEM of tumor size (A), survival (B), and tumor latency (C) in C57BL/6J mice 
under LD and CJL conditions injected subcutaneously with 30,000 cells of the murine melanoma cell line B16F0. Tumor latency: day of tumor detection by palpation 
(approximately 1 mm3). (A) Repeated-measures ANOVA interaction time × light schedule, P < 0.0001, post hoc test: day 33: CJL: 1607.5 ± 431.7 mm3, LD: 432.7 ± 272.9 mm3, 
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likely favored at all times (LD Night versus CJL Night: P = 0.0038; 
table S1).
Together, the data obtained for the M1 and M2 macrophages 
suggest that (i) under normal LD conditions, there is a daily pattern 
in the levels of M1 and M2 cells in the tumor, which translates into 
daily variations in the M1/M2 ratio, with the antitumor immunity 
being favored during the night, and (ii) circadian disruption not 
only induces the loss of these daily patterns but also decreases the 
M1/M2 ratio, which could facilitate the tumor growth.
In this context, we chose to evaluate the levels of proinflammatory 
cytokines interleukin-1 and interleukin-6 (IL-1 and IL-6) and tu-
mor necrosis factor– (TNF-; Fig. 2, D to F). Circadian oscillation 
of the mentioned cytokines was previously observed in macrophages 
in vitro (13–15). Intratumor levels of IL-1 and IL-6 switched from 
a daily cycle variation under LD conditions to a largely invariant 
level under CJL (IL-1: LD Day versus LD Night: P = 0.019 and LD 
Night versus CJL Night: P = 0.027; Fig. 2, D and E). Unlike interleu-
kins, TNF- also maintained distinct expression levels in a daily 
cycle within the tumor but appeared to be in antiphase in samples 
from animals treated under LD and CJL conditions (LD Day versus 
LD Night: P = 0.03, CJL Day versus CJL Night: P = 0.04, LD Night 
versus CJL Night: P = 0.038; Fig. 2F).
The outcome of tumor growth is tightly linked to the balance 
among infiltrating leukocytes with antagonistic functions, which con-
stitutes the tumor-immune microenvironment [reviewed in (8)]. 
To obtain a more accurate representation of the changes in intra-
tumor leukocyte populations in animals subjected to circadian dis-
ruption, we also analyzed the total leukocyte (CD45+ cells) percentage 
and its composition (i.e., Tregs and MDSCs; fig. S2 and table S1). Our 
results indicate that tumor samples from animals maintained under 
the CJL schedule have higher levels of leukocytes than animals sub-
jected to LD conditions (LD versus CJL: P = 0.01; table S1), without 
time-dependent differences in accumulation (LD Day versus LD 
Night: P = n.s.; CJL Day: versus CJL Night: P = n.s.; table S1 and fig. 
S2A). Accordingly, total T helper lymphocytes (CD4+) showed a 
modest, yet substantial intratumor accumulation, which was larger 
in CJL-treated animals than in LD-treated animals (LD versus CJL: 
P = 0.038; table S1) and remained unaltered over the different time 
points (LD Day versus LD Night: P = n.s., CJL Day versus CJL 
Night: P = n.s.; table S1 and fig. S2B). T regulatory CD4+ lympho-
cytes and MDSC accumulation among treatments were not signifi-
cantly different, although increased intratumor levels of these cells 
are usually associated with higher tumor grade and poorer progno-
sis in some cancers [fig. S2, C and D, and table S1 (8)].
Overall, our results favor a model in which circadian disruption 
modifies the immune microenvironment, which, in turn, could fa-
cilitate tumor growth. The decrease in the M1/M2 ratio observed 
during the night in tumors of mice under CJL would tilt the balance 
toward a more tolerogenic immune profile, which promotes tumor 
progression.
Circadian deregulation and tumor growth alter macrophage 
distribution in peripheral organs
To evaluate the impact of circadian desynchronization on the im-
mune system, we analyzed the temporal distribution of immune 
cells in the spleen of control animals (without tumor; Fig. 3, A to E). 
We reasoned that alterations in the peripheral immune response 
could be related to the shorter tumoral latency observed in mice 
under CJL conditions. In addition, because the presence of the tu-
mor can influence the immune response, we also assessed the com-
bined effect of tumor presence and circadian desynchronization on 
spleen immune cells.
Fig. 2. Daily pattern of immune parameters in tumor under CJL conditions. Mean ± SEM of the percentage of M1 (A) and M2 (B) macrophages, and the M1/M2 ratio 
(C) in tumor samples detected by flow cytometry taken at ZT3, ZT9, ZT15, and ZT21 as described in fig. S4, and mean ± SEM of protein levels of IL-1 (D), IL-6 (E), and TNF- 
(F) in tumor tissue samples taken at ZT6 and ZT18 (day and night, respectively) measured by ELISA. (A) Kruskal Wallis test: P = 0.028, LD: ZT3: 10.09 ± 1.90%, ZT9: 
5.41 ± 0.43%, ZT15: 16.07 ± 2.0%, ZT21: 12.99 ± 3.80%; CJL: ZT3: 9.55 ± 2.12%, ZT9: 10.15 ± 1.65%, ZT15: 3.49 ± 1.79%, ZT21: 5.51 ± 2.26; post hoc test: *P < 0.05. (D) Two-way 
ANOVA: interaction time × light schedule: P = 0.038, LD Day: 1.55 ± 0.04 pg/mg, LD Night: 1.03 ± 016 pg/mg, CJL Day: 1.48 ± 0.04 pg/mg, CJL Night: 1.55 ± 0.18 pg/mg; post 
hoc test: *P = 0.019 for LD Day versus LD Night, and *P = 0.027 for LD Night versus CJL Night. (F) Two-way ANOVA: interaction time × light schedule: P = 0.0067, LD Day: 
1.48 ± 0.06 pg/mg, LD Night: 0.90 ± 0.19 pg/mg, CJL Day: 1.03 ± 0.06 pg/mg, CJL Night: 1.52 ± 0.21 pg/mg, post hoc test: *P = 0.03 for LD Day versus LD Night, *P = 0.04 for 
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We first addressed whether the distribution of spleen M1 and 
M2 macrophages was influenced by changes in circadian synchro-
nization (Fig. 3, A to C, and table S1). Thereby, in animals without 
tumor, our results showed an increased level at ZT3 and ZT9 for 
both M1 and M2 cells compared to ZT15 and ZT21 (M1: P < 0.05 
for ZT3 versus ZT15 and ZT9 versus ZT15 and ZT21; M2: P < 0.05 
for ZT3 and ZT9 versus ZT15 and ZT21; Fig. 3, A and B, respective-
ly). Moreover, these results were consistent with a daily pattern of 
M1 and M2 percentages in this tissue, with higher levels during the 
day for both types of cells (without tumor: M1: LD Day versus LD 
Night: P = 0.000016; M2: LD Day versus LD Night: P = 0.000038; 
table S1). Circadian desynchronization was sufficient to suppress 
LD patterns of M1 and M2 levels in the spleen, which, per se, could 
be a contributing factor favoring early stages of tumor development 
(M1 and M2: P = n.s. for all comparisons; Fig. 3, A and B, respec-
tively). Moreover, when we compared the daily pattern from LD 
with CJL, we found a decrease in M1 diurnal levels under CJL con-
ditions (M1: CJL Day versus CJL Night: P = n.s., LD Day versus CJL 
Day: P = 0.001; table S1), which was not compensated for during the 
night as was observed for M2 cells (M2: CJL Day versus CJL Night: 
P = n.s.; LD Day versus CJL Day: P = 0.0005; LD Night versus CJL 
Night: P = 0.049; table S1). However, we did not find significant 
differences in the M1/M2 ratio between these samples (M1/M2: 
P = n.s. for all comparisons; Fig. 3C and table S1).
Next, we evaluated the effect that tumor growth had on macro-
phage distribution in the host spleen under LD and CJL conditions 
(with tumor; Fig. 3, F to J). Our results showed that the sole pres-
ence of the tumor was sufficient to influence the polarization of 
macrophages under LD conditions compared to sham animals. For 
both M1 and M2 cell types, the daily pattern was abolished, with 
maximum levels at all time points (LD: M1 and M2: P = n.s. for all 
comparisons; Fig. 3, F and G, and table S1). In tumor-bearing animals 
under CJL, the levels of M1 and M2 cells were similar to those under 
LD, suggesting that the impact of the presence of the tumor is more 
relevant than the circadian effect (CJL: M1 and M2: P = n.s. for all 
comparisons; Fig. 3, F and G, and table S1). As expected, we did not 
find any significant difference in the M1/M2 ratio between these 
groups (M1/M2: P = n.s. for all comparisons; Fig. 3H and table S1).
In addition, the percentage of total LT CD4+ and Tregs in spleen 
did not present daily differences and their levels were similar be-
tween both light schedules and in animals with or without tumors 
(Fig. 3, D, E, I, and J, and table S2), suggesting that these variables 
do not participate in the increased tumor growth rate observed in 
desynchronized mice. Together, our results emphasize a connection 
between components of the tumor microenvironment, particularly 
macrophages, and circadian variables that are altered in peripheral 
tissues under chronic circadian desynchronization. Thus, we spec-
ulate that circadian desynchronization in peripheral organs, e.g., 
spleen, resulting from a CJL schedule would favor the early stages of 
tumor development.
Circadian disruption alters the expression pattern of clock 
genes in the liver
To gain a deeper understanding of the contribution of host and tu-
mor clocks to the rate of abnormal tumor growth, we monitored the 
oscillatory expression of the core clock genes Bmal1 and Cry1 using 
real-time polymerase chain reaction (PCR) in liver samples obtained 
from mice maintained under LD or CJL schedules (Fig. 4). As ex-
pected, the mRNA levels of Bmal1 and Cry1 exhibited a rhythmic 
expression pattern in the liver of animals maintained under con-
stant LD conditions and in the absence of tumors [cosinor: Bmal1: 
P = 0.006, acrophase = 23.59 hours; Cry1: P = 0.024, acrophase = 
21.23 hours; Fig. 4, A and B, and table S2 (16)]. When similar stud-
ies were carried out in sham animals exposed to a CJL schedule, the 
oscillation of Bmal1 and Cry1 genes, measured by the cosinor method, 
Fig. 3. Daily pattern of immune cells in spleen tissue of mice carrying tumors 
under CJL conditions. Mean ± SEM of the percentage of M1 (A and F) and M2 
(B and G) macrophages, M1/M2 ratio (C and H), LT CD4+ (D and I), and LT Treg (E and 
J), detected by flow cytometry, in spleen tissue of control mice (A to D) or tumor- 
bearing mice (E to I) maintained under an LD or CJL schedule. (A) Kruskal-Wallis 
test: P = 0.01, LD: ZT3: 3.05 ± 0.43%, ZT9: 3.85 ± 0.29%, ZT15: 1.16 ± 0.27%, ZT21: 
1.72 ± 0.18%; CJL: ZT3: 2.06 ± 0.34%, ZT9: 1.76 ± 0.20%, ZT15: 1.69 ± 0.60%, ZT21: 2.55 ± 
0.14%. (B) Kruskal-Wallis test: P = 0.017; LD: ZT3: 0.63 ± 0.12%, ZT9: 0.79 ± 0.03%, 
ZT15: 0.21 ± 0.05%, ZT21: 0.12 ± 0.03%; CJL: ZT3: 0.17 ± 0.17%, ZT9: 0.50 ± 0.15%, 
ZT15: 0.51 ± 0.06%, ZT21: 0.44 ± 0.10%. For (C to H) Kruskal-Wallis test: P = n.s.; post 









Aiello et al., Sci. Adv. 2020; 6 : eaaz4530     14 October 2020
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
5 of 12
was deemed not significant (Fig. 4, C and D, and table S2). Never-
theless, analysis of variance (ANOVA) analyses showed marginal, 
yet significant, daily differences of mRNA expression for Bmal1 and 
Cry1 that peaked during the day. These results suggest that the liver 
circadian clock is altered but not completely abrogated. In this con-
text, CJL might cause a phase advance in the rhythmic expression of 
clock genes that peak at ZT3, 3 and 6 hours later than the acrophases 
for Bmal1 and Cry1 observed under LD conditions, respectively 
(23.59 and 21.23 hours).
Next, we determined whether animals bearing tumors exhibit a 
distinct circadian phenotype in their peripheral liver clock. Whereas 
the pattern of clock gene expression remained largely similar to 
control animals (without tumor) maintained under a normal pho-
toperiod (cosinor: Bmal1: P = 0.028, acrophase = 22.85 hours; Cry1: 
P = 0.006, acrophase = 19.68 hours; Fig. 4, E and F, and table S2), 
those exposed to a CJL schedule showed, again, relevant differences 
compared to control mice (Fig. 4, G and H, and table S2). These 
results suggest that the changes observed in clock gene expression 
in the liver are mainly the result of changes in the circadian sched-
ule and that the presence of the tumor does not play a substantial 
role in such alterations.
The oscillations of Bmal1 and Cry1 are abrogated 
in the tumor tissue
Clock function was then monitored in tumoral tissue extracted at 
different times from animals maintained under different light sched-
ules (fig. S3). The expression of Bmal1 and Cry1 genes did not show 
a rhythmic pattern under either an LD or CJL schedule (fig. S3, A to 
D). The lack of rhythmic patterns in these genes could be associated 
with a difference in the phase of the rhythms in each individual cell. 
However, the absence of differences between LD and CJL samples 
suggests that the expression of the clock genes Bmal1 and Cry1 in 
the tumor itself may not be implied in the increased growth rate un-
der desynchronized conditions but could instead be related to de-
regulation of time-dependent gene expression in tumoral cells.
Cell cycle progression is compromised in hepatocytes 
exposed to chronic circadian disruption
Differentiated mammalian hepatocytes have the unique ability to 
exit quiescence and reenter the cell cycle as a result of physical (e.g., 
partial resection) or mitogenic stimuli, for which the presence of 
proinflammatory cytokines remains a required priming event (17). 
TNF- and IL-6, two of the cytokines we found to be deregulated in 
tumor-bearing CJL-treated animals, are among the ligands favoring 
G0-G1 transition and are required for the establishment of early G1 
in vivo during liver regeneration (18). As a result, we first determined 
whether alterations in the immune makeup of animals exposed to 
circadian disruption translate into hepatocyte cell cycle remodeling 
in vivo and then evaluated whether the observed phenotype was al-
tered in tumor-bearing animals (Fig. 5).
Initially, mice were exposed to LD or CJL light schedules, the 
liver tissue was excised at different time points, and markers for cell 
cycle progression were assessed. We chose to monitor mRNA levels 
of G1-S and G2-M cyclins and of the cyclin/cyclin-dependent kinase 
(Cdk) inhibitor p21WAF/CIP1 (Cdkn1a) as these markers have been 
extensively characterized and represent entry into and progression 
through the cell cycle. In agreement with the in vivo quiescent na-
ture of hepatocytes, the gene expression profile of CcnE1, CcnA2, 
and CcnB1 (which encode for cyclins E, A2, and B1, respectively) 
exhibited low levels of expression in liver samples from animals ex-
posed to a normal LD schedule (Fig. 5, A to C). Our results suggest 
that some hepatocytes might progress from quiescence to early G1, 
as evidenced by a modest, yet significant, rise and progressive de-
cline in the CcnE1 level detected within the ZT9 and ZT15 window 
in LD samples (LD: ZT9 versus ZT18: P < 0.05; Fig. 5A). A basal 
level of CcnA2 expression was identified, overlapping with CcnE1 at 
Fig. 4. Rhythms of clock genes in liver under the CJL schedule. Mean ± SEM of relative mRNA levels of Bmal1 (A, C, E, and G) and Cry1 (B, D, F, and H) in the livers of 
mice carrying tumors (E to H) or controls (A to D), under LD (A, B, E and F) and CJL (C, D, G, and H) conditions detected by real-time PCR in eight time points (ZT0, ZT3, ZT6, 
ZT9, ZT12, ZT15, ZT18, and ZT21). Curves plotted over the data (A, B, and E to G) correspond to cosinor analysis adjusted to 24 hours. Only the statistically significant cosinor 
analyses were plotted (table S2). Nonparametric Kruskal-Wallis test: (A) P = 0.001, (B) P = 0.002, (C) P = 0.007, (D) P = 0.016, (E) P = 0.016, and (F) P = 0.048; post hoc test: 
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ZT9 to ZT15 (Fig. 5B); thus, our results support a model in which 
cells become arrested at a restriction point located in mid-late G1. 
This assumption is supported by the observation that p21WAF/CIP1 
accumulation occurred within the same time frame than the expres-
sion of G1-S cyclins (cosinor: P = 0.04; Fig. 5D and table S2) and that 
the level of CcnB1 remained low and invariable at all times (Fig. 5C).
The effect of the CJL schedule in the expression of cell cycle com-
ponents was particularly noticeable when monitoring the mRNA 
profile of p21WAF/CIP1 in liver samples (Fig. 5H). Figure 5 shows that 
the cyclin/Cdk inhibitor level (Cdkn1a) remained steady and low at 
all times under the CJL condition compared to LD (Fig. 5, D versus 
H). In addition, the profile of G1-S cyclins was perturbed under a 
CJL schedule (Fig. 5, E to G) as reflected by the peak of maximum 
expression of cyclin E1 being shifted when compared to LD (i.e., 
CcnE1; Fig. 5, A versus E). Overall, these data suggest that the liver 
tissue from animals subjected to a CJL schedule exhibits perturba-
tion at the cellular level, which could make the hepatocytes entirely 
competent to mitogenic and inflammatory signals.
We then determined whether the presence of a nonmetastatic 
tumor alters the molecular makeup of the liver favoring a prolifera-
tive state when animals were subjected to distinct light schedules. As 
shown in Fig. 5 (I to L), the sole presence of the tumor led to CcnE1 
up-regulation (by comparing the confidence interval of the mesor 
in table S2 and Fig. 5, A versus I) and p21WAF/CIP1 dampening (co-
sinor: P = n.s.; table S1 and Fig. 5, D versus L) under LD conditions, 
suggesting that progression to late G1 was favored. However, most 
cells likely remained uncommitted to DNA replication due to the lack 
of CcnA2 expression (Fig. 5J).
The liver proliferative phenotype was enhanced in the presence 
of a tumor and under conditions of CJL (confidence interval of the 
mesor in table S2 for CcnE1: LD without tumor versus CJL with tumor, 
CcnA2: LD with tumor versus CJL with tumor, CcnB1: LD without 
Fig. 5. Rhythms of cell cycle–related molecules in liver under a CJL schedule. Mean ± SEM of relative mRNA levels of the CcnE1 (A, E, I, and M), CcnA2 (B, F, J, and N), 
and CcnB1 (C, G, K, and O) and the inhibitor p21WAF/CIP1 (Cdkn1a; D, H, L, and P) in liver tissues of control mice (A to H) or mice carrying tumors (I to P), under LD (A to D and 
I to L) or CJL (E to H and M to P) conditions, detected by real-time PCR in eight time points (ZT0, ZT3, ZT6, ZT9, ZT12, ZT15, ZT18, and ZT21). Curves plotted over the data 
(C and D) that correspond to the cosinor analysis were adjusted to 24 hours. Only statistically significant cosinors were plotted (table S2). Kruskal-Wallis test: (A) P = 0.011, 
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tumor versus CJL with tumor, Cdkn1a: LD with tumor versus CJL with 
tumor; table S2 and Fig. 5, M to P). Accordingly, both G1-S and G2-M 
cyclins showed an enhanced, cascade-like (CcnE1, CcnA2, and CcnB1; 
Fig. 5, N to P) expression of CcnE1, which was detected in early and 
late G1 and before S-phase entry (Fig. 5M), whereas detectable levels 
of CcnA2 and CcnB1 were observed before or during G2-M transi-
tions (Fig. 5, N and O). We speculate that the enhanced proliferative 
phenotype observed in the liver tissue of tumor-bearing animals might 
have been facilitated by the accumulation of proinflammatory cyto-
kines that made the hepatocytes competent to mitogenic signals.
Circadian modulation of cell cycle gene expression in tumor
Last, we evaluated whether chronic circadian deregulation affects 
the expression of cell cycle components in the tumor or, instead, 
disrupts their daily oscillation. Accordingly, tumor samples from 
animals maintained in either LD or CJL schedules were collected at 
different times and their expression was monitored by real-time 
quantitative reverse transcription PCR (Fig. 6). In agreement with 
the cell proliferative status within the tumor, mRNA expression of 
p21WAF/CIP1 (Cdkn1a) remained at low levels throughout the time 
course analyzed (Fig. 6, A and B). Whereas exposure to CJL has a 
negligible effect on the expression and oscillation of the cyclin E1 
and B1 transcripts (Fig. 6, C to E and I to K), both remained detect-
able and largely steady at all times; the expression of CcnA2 exhibited 
a sustained increase (Fig. 6, F versus G: ZT9 to ZT15; Fig. 6H). 
These results suggest that, in addition to promoting tumor prolifer-
ation by developing a favorable immune niche, chronic disruption 
favors the up-regulation of key regulatory components, such as CcnA2, 
which favors cell cycle transitions.
DISCUSSION
The CJL protocol used in this work, 6-hour advances of the LD cy-
cle every 2 days, generates an internal circadian desynchronization 
in which animals fail to entrain to the environmental cycle (9). Our 
results show and confirm an increased rate of tumor growth in mice 
under circadian disruption. Here, we first confirm data previously 
reported using different carcinogenesis models and light schedules 
of circadian disruption [CJL and constant light (6, 19–24)]. More-
over, mice carrying mutations of clock genes (22, 25) or those whose 
SCN was ablated (26) also showed an increased rate of tumoral 
growth. In addition, we report a decrease in tumor latency indicating 
an early effect of the circadian disruption protocol over the progres-
sion of the disease.
Our main hypothesis was that desynchronization of the immune 
response could be involved in increased tumor growth rate in mice 
maintained under a CJL schedule. In this context, we first analyzed 
immune variables under normal LD conditions and found a daily 
pattern in the percentage of M1 and M2 macrophages in the spleen 
and in the tumor, as well as a daily variation in cytokine levels in the 
tumor. Specifically, our results showing higher levels of cytokines 
during the day are in line with reports showing a higher activity of 
macrophages (phagocytosis and cytokine secretion in vitro) in this 
phase of the LD cycle (13, 14). Circadian regulation of macrophage 
function is also evidenced by the loss of rhythmic patterns in these 
cells in macrophage-specific Bmal1−/− mice (15). Overall, these data 
show not only that the macrophages have an internal clock but also 
that the clock is synchronized differentially depending on the tissue 
and functional profile.
Proinflammatory cytokines, mainly IL-1 and TNF-, are usual-
ly associated with M1 macrophages (27). The apparent contradic-
tion between the higher levels of these cytokines during the day and 
the higher percentage of M1 macrophages during the night in the 
tumor could be related to the presence of other cell types in this tissue, 
such as DC or T helper CD4+, or with the time it takes macrophages 
to differentiate and synthesize these molecules. In addition, it is im-
portant to mention that the M2 macrophages may exhibit different 
profiles that are not fully characterized (generally known as M2a, 
M2b, M2c, and M2d) and that some of them can secrete proinflam-
matory cytokines (28).
We also report that the CJL schedule induces the loss or inver-
sion of the daily immune patterns observed under LD conditions, 
both in the spleen and in the tumor. In rats carrying tumors, NK 
cells from the spleen showed higher nocturnal levels of granzyme B, 
perforin, and interferon-, which were lost under a CJL schedule 
(6). Similarly, changes in the immune microenvironment inside the 
tumor, particularly in macrophage and T helper lymphocyte pro-
files, have been recently reported in a different murine model of 
tumorigenesis subject to circadian deregulation (29). Together, these 
data suggest a strong effect of circadian desynchronization on the 
immune system. The M1/M2 ratio, which showed higher values 
during the night under LD conditions, decreased under the CJL 
schedule. This change suggests a functional defect in the immune 
system inside the tumor, because a decrease in the M1/M2 ratio has 
been associated with a worsening prognosis in tumors (12). In addi-
tion, the higher levels of leukocytes (total CD45+ and LTh CD4+) 
observed in the tumors of animals subjected to CJL could be related 
to the deregulation of macrophage LD patterns because of their 
main role as chemokine producers. Here, we show that the increase 
of total leukocytes is not due to an increase in the percentage of total 
macrophages, MDSCs, or Tregs. These results are in line with reports 
showing that immune infiltration of monocytes, DCs, and lympho-
cytes did not change after synchronizing tumor tissue with dexa-
methasone (30), all of which point to the need for a more thorough 
characterization of specific profiles of immune cells and secreted 
chemokines. For example, the recruitment of monocytes to inflam-
matory sites is mediated by the CCL2 ligand (also known as MCP-1), 
an important chemoattractant that is regulated in a diurnal fashion 
and secreted by macrophages, among other cells (31). It was shown 
that BMAL1 is necessary to generate the rhythmic oscillations in 
Ccl2 expression via BMAL1/CLOCK binding to E-box motifs in the 
Ccl2’s promoter and recruitment of members of the repressor com-
plex polycomb repressive complex 2 (PRC2) (31). We previously 
showed that CCL2, which has a rhythmic mRNA expression in the 
SCN, is involved in circadian-immune bidirectional regulation (32). 
As a result, we could not rule out that the altered pattern of immune 
variables reported in the present work results from deregulation in 
the circadian expression of the CCL2 chemokine. For another 
chemokine pathway, the Cxcr2 inhibitor SB265610 was able to re-
verse JL-induced metastases and changes in immune cells (29). In 
this context, it has been reported that chronic circadian deregulation 
can modify both the endogenous clock and the immune phenotypes 
and functions of macrophages (33, 34). One possible mechanism to 
explain the increased tumoral growth rate in mice under the CJL 
schedule could be that the macrophage internal clock is impaired or 
deregulated, as we have found in liver tissue. In turn, this would 
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As previously mentioned, chronic inflammation may be related 
to tumor progression. T helper 17 (TH17) cells in some tumors act 
as promoters of chronic inflammation (8). However, in melanoma, 
these cells seem to be involved in the tumor regression process. In 
addition, the TH17/Treg rate inside the tumors is particularly rele-
vant because they share differentiation pathways (35). Differentia-
tion from CD4+ naive T cells to a TH17 profile is under circadian 
regulation through the inhibitory transcription factor NFIL3, which 
is regulated by Rev-erb-. Accordingly, the TH17 lineage is altered 
in Rev-erb-−/− mice. In addition, light cycle disruptions increased 
intestinal TH17 cell frequencies and susceptibility to inflammatory 
disease (36). Furthermore, melatonin induces the expression of the 
repressor NFIL3, blocking differentiation to TH17 cells and pro-
moting the generation of Tregs and expression of IL-10 through in-
duction by ROR- (37). Deregulation in the TH17 differentiation 
pathway induced by the CJL schedule may be related to the tendency 
to increase CD4+ Tregs (FoxP3+) in the tumors reported in the pres-
ent study.
The CJL schedule altered the rhythmic expression patterns of 
the clock genes Bmal1 and Cry1 in the liver of control animals. The 
analysis of the rhythms of clock gene expression in the liver is rele-
vant because it has been related to hepatocarcinogenesis (21). In 
addition, a complete loss of circadian rhythms in clock gene expres-
sion in several tissues has been reported in animals maintained un-
der different CJL schedules (21, 38). In line with our results, analysis 
of the molecular clock in muscles and lungs demonstrated that CJL 
schedules that advance the LD cycle 6 hours every 4 days induce an 
advance in the phase of the rhythm when studied immediately after 
CJL (39). Similarly, clock gene expression is phase-shifted in the 
spleen of control rats under a 6-hour advance every 2 days (6). Like-
wise, a phase shift in clock gene expression in the liver has been re-
ported in tumor-bearing mice maintained under different CJL 
schedules (20, 38).
As previously mentioned, the CJL schedule used in this work 
induces an activity pattern that includes two components of activity 
rhythm with periods of about 21 and 24.7 hours. It is possible to 
Fig. 6. Daily pattern of cell cycle–related molecules in tumor tissue under a CJL schedule. Mean ± SEM of relative mRNA levels of the inhibitor p21WAF/CIP1 (Cdkn1a) 
(A and B), and CcnE1 (C and D), CcnA2 (F and G) and CcnB1 (I and J) in tumor tissue of mice under LD (A, C, F, and I) and CJL (B, D, G, and J) conditions detected by real-time 
PCR at eight time points (ZT0, ZT3, ZT6, ZT9, ZT12, ZT15, ZT18, and ZT21), and mean ± SEM of 24-hour mean levels of CcnE1 (E), CcnA2 (H), and CcnB1 (K). Curves plotted 
over the data (A) correspond to cosinor analysis adjusted to 24 hours. Only the statistically significant cosinor analyses were plotted. Student t test: *P < 0.05; n = 3 to 4 per 
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divide this pattern in four phases: two “aligned” (activity or rest for 
both components) and two “misaligned” (activity for one compo-
nent and rest for the other, in both directions). Although there are 
no data on the phases in peripheral tissues, we might speculate that 
when the phases are aligned, the peripheral rhythms will be more 
similar to a normal LD cycle, and in the misaligned condition, these 
variables lose their daily differences.
A potential confounding factor for the effect of circadian disruption 
is the lack of information about the “internal time” of the mice at 
the moment of the inoculation of tumor cells. The relative meaning 
of the different body rhythms (e.g., activity rhythms, temperature 
rhythms, and hormone rhythms) in this specific context is not yet 
fully understood. We established a 2-hour window for inoculation 
(ZT9 to ZT11) on the day following the 12-hour night of the CJL 
schedule. Moreover, because tumor development occurred through-
out several desynchronization events (eight phase shifts per week), 
we could speculate that the differential tumoral growth depended 
on the complete schedule of disruption (30 to 45 days) and not nec-
essarily on the time of inoculation. While we interpreted that the 
CJL protocol could affect the proliferation rate of the tumor cells and/
or the antitumoral immune response, the circadian timing of inoc-
ulation could also modify the percentage of mice that developed tumors 
(a variable frequently reported in the existing literature), because 
the immune defense mechanisms would be different throughout 
the day.
Circadian regulation of the expression and activity of cell cycle–
related molecules has been reported extensively, and circadian 
rhythms have been observed in the levels of c-Myc; cyclins E, A, B1, 
and D1; and the inhibitors Wee1, p16, p21, and p53, among others, 
in different systems [reviewed in (40, 41)]. In addition, the distribu-
tion of the phases of the cell cycle (G1-S-G2) and the expression levels 
of molecules involved in apoptosis exhibit circadian rhythms in the 
bone marrow of mice (42). Here, we show that the daily expression 
pattern of cell cycle–related molecules observed under LD condi-
tions was modified in the liver of mice maintained under the CJL 
schedule. In particular, the mRNA levels of the inhibitor p21WAF/CIP1 
lost their rhythmic expression patterns, while CcnE1 rhythms were 
dampened. In line with our results, it was reported that the circadi-
an expression of the proto-oncogene c-Myc, the cyclin D1, and the 
tumor suppressor Gadd45 was modified in the liver of Per2 mutant 
mice (43), with an increase of c-Myc levels, a decrease of Gadd45 
levels, and a phase shift of the circadian expression pattern of cyclin 
D1. Moreover, circadian clock disruption induced by a CJL sched-
ule down-regulates p53 and up-regulates c-Myc levels in the liver of 
mice (44). Furthermore, chronic circadian desynchronization in-
duces multiple oncogenic pathways to promote cell proliferation, 
thereby favoring G1-S phase cell cycle progression (45). In addition, 
using a model of liver regeneration in mice, it has been shown that 
the circadian clock modulates the expression of cyclin B1, Cdc2 ki-
nase, and wee1 (46). In particular, wee1 could be transcriptionally 
regulated by Bmal1/Clock through the E-box sequences present in 
its promoter region. Here, we explored the mRNA levels of cell cycle– 
related molecules, but not their protein products, their activation 
levels, or the cell cycle phases; however, our results suggest an im-
portant deregulation of cell cycle–related transcription induced by 
circadian desynchronization.
As we previously mentioned, the night-day crepuscular peak of 
p21WAF/CIP1 in the liver was lost in desynchronized animals, exhib-
iting low levels throughout the day. Similar LD patterns were reported 
in liver, heart, and skeletal muscle (47). In addition, the liver expres-
sion of p21WAF/CIP1 was increased in Bmal1-deficient mice (47). 
However, as the p21WAF/CIP1 promoter lacks E-box sequences, it is 
unlikely to be regulated directly by Bmal1/Clock. The expression of 
this molecule is regulated by Rev-erb- (inhibitor) and ROR-/
ROR- (stimulator) through the RORE sequences present in its 
promoter region (46). Moreover, it is interesting that, in line with 
our observation about p21, circadian patterns of p53 in the thymus 
also became arrhythmic under a CJL schedule (22). On the other 
hand, an increased rate of cell division in the liver of mice main-
tained under a CJL schedule has been reported and was associated 
with the development of nonalcoholic fatty liver disease and hepa-
tocarcinogenesis (21). This fact could be related to the decreased 
levels of the mentioned inhibitors p21 and p53.
In tumor tissue, we did not observe any rhythmic pattern in the 
mRNA levels of clock genes or cyclins. Similar results were recently 
published using the same tumor model (30). It is interesting that the 
intratumoral injection of dexamethasone in mice under an LD 
schedule not only reduced tumor growth rate but also induced the 
rhythmic expression of clock genes and a rhythmic pattern of mito-
sis and apoptosis in B16 melanoma tumors. These data show the 
relevance of studying (and inducing) rhythmic patterns inside the 
tumors.
However, it is important to emphasize that we measured the mRNA 
levels from a whole tumor tissue’s fragment but did not evaluate the 
single-cell clock function. In this context, it is possible that each tu-
mor cell maintains their rhythmic, cell-autonomous clock gene ex-
pression, but it is not identified because each cell exhibits a different 
circadian phase and the individual levels of these genes were com-
pensated and, thus, invariant in the whole tissue extract. On the 
other hand, it is also possible that the circadian disruption observed 
in immune cell patterns inside the tumor affects the clock gene ex-
pression in the tumor cells through the secreted cytokines, because 
it has been reported that these molecules (e.g., TNF-, IL-1, and CCL2) 
can modulate the molecular clock mechanism both in vitro and 
in vivo (32, 48).
On the other hand, we observed that the levels of CcnA2 were 
increased under CJL conditions. Despite the circadian expression of 
clock genes in several tumor cell lines in vitro, clock gene expres-
sion is generally impaired in most human cancers (40). Moreover, 
the number of rhythmic genes is reduced in human cancer samples 
and in immortalized cell lines compared to normal tissues (40). In 
addition, c-Myc levels inversely correlated with Bmal1, Clock, and 
Cry1/2 levels in human lymphomas. C-Myc is a transcription factor 
that binds the genome through E-boxes, the same binding sites of 
the Bmal1/Clock heterodimer. It has been reported that c-Myc in-
hibits clock gene expression in U2OS cells (49). Together, these data 
indicate a direct relationship between circadian and cell cycle–related 
molecules inside the tumors, which suggests that in our CJL model, 
deregulation of clock genes is part of the mechanism that affects 
tumoral transcription and activity.
In conclusion, our results suggest that circadian disruption could 
facilitate tumoral growth by modulating immune response and cell 
cycle–regulated factors. Specifically, we demonstrated that the cir-
cadian pattern of the immune response in the spleen and in the tu-
mor, particularly in the percentage of pro- and anti-inflammatory 
macrophages, is deregulated under circadian desynchronization. The 
decrease in the M1 cells (and M1/M2 ratio) observed under CJL 
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which promotes tumor escape and tumoral progression. The pe-
ripheral immune desynchronization observed in the spleen of con-
trol animals maintained under the CJL schedule could affect the early 
stages of tumor development. In addition, animals subjected to a CJL 
schedule exhibited perturbations at the cellular level, which seems 
to make the liver cells competent to mitogenic signals. Our data sug-
gest that desynchronization of the daily patterns of proinflammatory 
cytokines could favor cells becoming competent to mitogenic signals.
MATERIALS AND METHODS
Animals
Adult (2-month-old) C57BL/6J wild-type (WT) male mice (Mus musculus) 
were raised in our colony. Mice were housed under a 12:12-hour LD 
photoperiod (with lights on at 7:00 a.m. and lights off at 7:00 p.m.) 
with food and water ad libitum for at least 2 weeks before entering 
into experimental conditions. All animal protocols were approved 
by the Ethics Committee of the National University of Quilmes, and 
experiments were carried out in accordance with international ethical 
standards for the care and use of laboratory animals.
Cell culture
The mouse melanoma cell line B16F0, from D. F. Alonso from the 
Oncology Laboratory of the National University of Quilmes, was cul-
tured in complete Dulbecco’s modified Eagle’s medium (Thermo 
Fisher Scientific) supplemented with 5% (v/v) fetal bovine serum (FBS) 
and maintained at 37°C in a humidified incubator with 5% CO2.
Experimental lighting schedules
Individually caged animals (C57BL/6J, males, 2 to 3 months old) 
were maintained for 3 weeks under light:dark (LD12:12) or CJL 
[6-hour advance of the LD12:12 cycle every 2 days, shortening of 
every second dark phase (9)] schedules with food and water ad libi-
tum. ZT was used as a temporal reference: ZT0 is the moment of lights 
on, and ZT12 is the moment of lights off. For the CJL schedule, sam-
ples were taken during the 12-hour night and on the following day. 
Effective circadian desynchronization was confirmed by individu-
ally monitoring locomotor activity rhythms using infrared sensors 
connected to a computer interface and by recording activity counts 
every 5 min. Data collection was used for posterior time series analysis 
(Archron, Buenos Aires, Argentina). In all cases, CJL-treated animals 
were confirmed for the presence of two components of activity rhythms 
with periods of ~21 and 24.7 hours as previously described (9).
In vivo experimental design
Mice were housed under either an LD or CJL schedule for 3 weeks 
before being inoculated with B16F0 cells or vehicle and maintained 
under the corresponding light schedule throughout the experimen-
tal procedure (until the end point of the tumorigenic protocol). To 
induce tumorigenesis, 30,000 cells were inoculated subcutaneously 
in the dorsal cephalad site of mice. Injections of all animals were 
carried out during a 2-hour window, ZT9 to ZT11, a time frame at 
which the day (which followed a 12-hour night) in CJL overlapped 
with that of the LD animals. Animals were manually palpated three 
times a week, and the day of tumor detection was recorded (latency 
to approximately 1 mm3). From then on, the tumor size was mea-
sured with a caliper three times a week. The experimental end point 
was defined by the size of the tumor (2000 to 2500 mm3 of volume) 
and in accordance with the Ethics Committee and Institutional An-
imal Care and Use guidelines of the National University of Quilmes. 
Animals were sacrificed at various ZTs (ZT0, ZT3, ZT6, ZT9, ZT12, 
ZT15, ZT18, and ZT21) when tumors reached the end point; this 
was in experiments that involved monitoring tumor growth, survival, 
and number of blood vessels. In cases where tissue gene expression 
and the immune makeup were monitored, samples were collected 
when tumors were of 1000 to 1500 mm3 volume.
Quantification of blood vessels in tumor samples
Tumor samples were excised, fixed in 4% paraformaldehyde, em-
bedded in paraffin, and stained using the hematoxylin and eosin 
method. Images (10 frames) were taken for the different tumor sec-
tions. Stained endothelial cells were visually identified and counted 
as surrounding blood vessel cells.
Neoangiogenesis
To determine neoangiogenesis, animals were intradermally coinjected 
with either B16F0 cells (100,000) or vehicle and trypan blue (0.2%) 
and sacrificed 7 days later. Blood vessel bifurcations were counted 
on the open skin. For accurate measurements, a 1.5-cm ruler was 
placed by the injection spot and pictures were taken. Blood vessel 
bifurcations were counted using ImageJ software (National Institutes 
of Health, Maryland, USA; https://imagej.nih.gov/ij/).
RNA extraction and real-time PCR
Liver and tumor tissues were carefully dissected from mice exposed 
to CJL or LD conditions. Total RNA was isolated using 300 l of 
TRIzol reagent (Life Technologies) according to the manufacturer’s 
instructions. RNA solutions were quantified using NanoDrop1000 
(Thermo Fisher Scientific), and their integrity was evaluated by 
electrophoresis. One microgram of total RNA was treated with RQ1 
RNase-Free DNase (Promega), and complementary DNA (cDNA) 
was synthesized using oligo(dT) primers and the SuperScript First-
Strand Synthesis System (Invitrogen). Gene amplification was per-
formed on a StepOne Plus Real-Time PCR instrument (Applied 
Biosystems), using 10 l of final reaction volume containing 0.5 l 
of cDNA as the template, 1× of the PerfeCTa FastMix II ROX 
(Quantabio, 95119-2), and the corresponding primers (table S3) at 
a final concentration of 200 to 400 nM. The cDNA template was 
amplified in triplicate, with the following conditions: 95°C for 
2 min, followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. 
Relative gene expression was calculated using the 2−∆∆Ct method, 
and hprt was the reference housekeeping gene.
Flow cytometry
Tumor and spleen tissues were collected in culture medium contain-
ing collagenase IV (1 mg/ml; Thermo Fisher Scientific). Following 
mechanical disruption, tissues were maintained at 37°C for 20 min 
before the collagenase activity was inhibited by adding 15% FBS. 
Next, cells were filtered with a 70-m filter, and red cells were incu-
bated with lysis buffer [NH4Cl (8290 g/ml), KHCO3 (1 g/ml), and 
EDTA 1 mM] in a 1:9 ratio and then centrifuged at 400g for 10 min 
at 4°C. About 1 × 106 cells were incubated with the indicated fluo-
rescent antibody (CD45, F4/80, CD11b, CD86, CD4, CD206, and Gr1; 
BioLegend) or their corresponding isotype control [phycoerythrin 
(PE) immunoglobulin G1a (IgG2a), PE IgG2b, PerCP7cy5.5 rat 
IgG2a, allophycocyamin (APC) rat IgG2a; BioLegend] for 30 min at 
room temperature. Cells were then washed with 3% phosphate- 
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CD4-labeled cells were fixed at 4°C for 30 min, permeabilized for 
30 min at 37°C using the FoxP3 buffer set (BD Pharmingen), and 
incubated with anti-FoxP3 (BioLegend) for an additional 30 min at 
room temperature. Fluorescence detection was carried out using a 
FACSCalibur flow cytometer (Becton Dickinson). Data were ana-
lyzed using FlowJo 7.6 software (http://flowjo.com).
The leukocyte population (CD45+) in tumor cell suspension was 
analyzed using a CD45 versus side-scattered dot plot, and the cell- 
specific markers were analyzed inside this gate (fig. S4). For M1 and 
M2 macrophage analysis, the F4/80+ (macrophage marker) popula-
tion was plotted for CD86 and CD206 markers, and CD86+CD206− 
cells were considered M1 and CD86−CD206+ cells were considered 
M2 [similar percentage of CD86+CD206+ population was observed 
in all group of samples (50)]. In addition, the M1/M2 ratio was cal-
culated in each sample. MDSCs were identified as CD11b+Gr1+ 
and Treg as CD4+FoxP3+. A similar procedure was followed to iden-
tify the spleen immune populations.
Cytokine detection in tissues
Tumor tissues from samples taken at ZT6 and ZT18 (day and night, 
respectively) were homogenized in PBS buffer containing a prote-
ase inhibitor cocktail (Sigma-Aldrich), incubated for 15 min at 4°C, 
and centrifuged at 14,000g for 15 min. Supernatants were collected, 
and protein concentration was measured using the Qubit Kit (In-
vitrogen). Concentration of cytokines TNF-, IL-6, and IL-1 was 
determined by enzyme-linked immunosorbent assay (ELISA; Becton 
Dickinson Company) following the manufacturer’s protocol.
Statistical analysis
Data are presented as mean ± SEM. Differences between two groups 
were analyzed using the unpaired Student’s t test. Differences be-
tween more than two groups were analyzed by one- or two-way 
ANOVA or the nonparametric Kruskal-Wallis test. The P values of 
0.05 or less were considered to be statistically significant. GraphPad 
Prism7 (GraphPad Software Inc.) and Infostat software were used 
to perform all statistical analyses. El Temps software was used for 
chronobiological analyses.
The two-way ANOVA was used to evaluate immunological pa-
rameter with the following factors being considered: time of sample 
extraction (day versus night), light schedule (LD versus CJL), and 
their interaction time × light schedule. The Kruskal-Wallis test was 
used to evaluate differences in gene expression among time points 
as experientially determined by real-time PCR. Cosinor analysis was 
additionally applied for the expression patterns that adjusted to 
cosenoidal curves with a period of 24 hours. Values of amplitude, 
acrophase, and mesor of the significant cosinor adjustments were used 
to plot the corresponding curves over the data. In expression pat-
terns without any significant difference between time points (Kruskal- 
Wallis test and cosinor analyses), the 24-hour mean levels were 
calculated by gathering the values obtained in all samples.
Chi-square periodograms were performed to confirm circadian 
desynchronization in CJL maintained mice. As expected (9), in all 
cases, we observed two rhythmic components with periods around 
21 and 24.7 hours.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/6/42/eaaz4530/DC1
View/request a protocol for this paper from Bio-protocol.
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